Document Detail


Identification of a hydroxylamine glucuronide metabolite of an oral hypoglycemic agent.
MedLine Citation:
PMID:  14744939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Glucuronides of piperazine hydroxylamines are rarely reported in the literature, and even more rarely are their structures unambiguously identified. One major metabolite was detected by liquid chromatography/mass spectrometry-radioactivity in urine from monkeys treated with the aryl piperazine oral hypoglycemic agent 9-[(1S,2R)-2-fluoro-1-methylpropyl]-2-methoxy-6-(1-piperazinyl) purine hydrochloride (1). The mass spectrum of this metabolite indicated that it was both monooxygenated and glucuronidated on the piperazine ring. Possible structures included the N- or O-glucuronic acid conjugates of a carbinolamine, hydroxylamine, or N-oxide. Treatment with beta-glucuronidase gave a monooxygenated derivative of the parent compound. 1H NMR analysis of either the glucuronic acid conjugate or the monooxygenated product provided insufficient evidence to unambiguously determine their structures. Incubation of 1 with pig liver microsomes resulted in formation of the same monooxygenated derivative derived from beta-glucuronidase treatment of the glucuronide metabolite. This in vitro system was used to generate sufficient material for analysis by 13C NMR, and the metabolite was identified as a hydroxylamine derivative 2. Incubation of the hydroxylamine with monkey liver microsomes and uridine diphospho-5'-glucuronic acid gave the same glucuronic acid conjugate as that observed in monkey urine. 13C NMR analysis of this biosynthetic product led to its unequivocal structure assignment as the O-glucuronic acid conjugate of the hydroxylamine 3.
Authors:
Randall R Miller; George A Doss; Ralph A Stearns
Related Documents :
5770619 - Feline attractant, cis,trans-nepetalactone: metabolism in the domestic cat.
3260239 - Direct and simultaneous high-performance liquid chromatographic assay for the determina...
509409 - Identification of s-(carboxymethyl)-l-cysteine and thiodiglycolic acid, urinary metabol...
4039459 - Further characterization of the endogenous natriuretic and digoxin-like immunoreacting ...
21549829 - Oxidative stress in human lymphocytes treated with fatty acid mixture: role of caroteno...
19866959 - The acid intoxication of diabetes in its relation to prognosis.
9044199 - Postinfective diarrhoea and bile acid malabsorption.
12076979 - A reassessment of the peroxynitrite scavenging activity of uric acid.
22975709 - Estradiol inhibits the activity of proton-coupled amino acid transporter pat1 expressed...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Drug metabolism and disposition: the biological fate of chemicals     Volume:  32     ISSN:  0090-9556     ISO Abbreviation:  Drug Metab. Dispos.     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-01-27     Completed Date:  2004-03-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421550     Medline TA:  Drug Metab Dispos     Country:  United States    
Other Details:
Languages:  eng     Pagination:  178-85     Citation Subset:  IM    
Affiliation:
Department of Drug Metabolism, Merck Research Laboratories, Rahway, NJ 07065, USA. randy_miller@merck.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Animals
Chromatography, High Pressure Liquid
Chromatography, Liquid
Glucuronides / biosynthesis,  metabolism*,  urine
Hydroxylamines / metabolism*,  urine
Hypoglycemic Agents / administration & dosage,  metabolism*,  urine
Macaca mulatta
Magnetic Resonance Spectroscopy
Male
Mass Spectrometry
Microsomes, Liver / enzymology
Piperazines / administration & dosage,  metabolism*,  urine
Species Specificity
Swine
Chemical
Reg. No./Substance:
0/Glucuronides; 0/Hydroxylamines; 0/Hypoglycemic Agents; 0/L 686398; 0/Piperazines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic ext...
Next Document:  Differential enantioselectivity and product-dependent activation and inhibition in metabolism of ver...